InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Howell Kelli Mari, Vice-Président Exécutif, Stratégies Cliniques. Officer active across 1 companies, notably Alphatec Holdings, Inc.. Cumulatively, 8 filings have been recorded. The latest transaction was disclosed on 18 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€28,9772,940 shares@ €9.85630.0025% mcap3.1% of flow
Common Stock
SEC:0001179110-22-002366:0·
025,000 shares0
Common Stock
SEC:0001179110-22-001694:0·
€77,8506,050 shares@ €12.86780.0066% mcap17.5% of flow
Common Stock
SEC:0001179110-21-008020·
€77,8506,050 shares@ €12.86780.0066% mcap8.5% of flow
Common Stock
SEC:0001179110-21-008020:0·
€213,49717,525 shares@ €12.18240.018% mcap47.9% of flow
Common Stock
SEC:0001179110-21-005569·
€213,49717,525 shares@ €12.18240.018% mcap23.2% of flow
Common Stock
SEC:0001179110-21-005569:0·
€154,50611,474 shares@ €13.46570.013% mcap34.7% of flow
Common Stock
SEC:0001179110-21-004763·
€154,50611,474 shares@ €13.46570.013% mcap16.8% of flow
Common Stock
SEC:0001179110-21-004763:0·
8 of 8 declarations
About Howell Kelli Mari
Kelli Mari Howell is Executive Vice President, Clinical Strategies at Alphatec Holdings, Inc. She is responsible for leading clinical initiatives and product development strategy. Her expertise in healthcare and clinical operations management is essential to support the company's growth.
